SCHEMBL30983904

SCHEMBL30983904

CC1(Oc2ccnc(NCc3cc(Cl)ccn3)c2N)CC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.38
▸ TLR7 Q9NYK1 1/20 0.38
▸ BACE1 P56817 2/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ WDR5 P61964 2/20 0.34
▸ THRB P10828 3/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ MAPK1 P28482 2/20 0.31
▸ STAT1 P42224 1/20 0.31
▸ RAF1 P04049 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ PDE8A O60658 1/20 0.30
▸ PGK1 P00558 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983969 0.81 ALDH1A1 (0.34) KCNH2TLR7BACE1KDM4EALDH1A1
SCHEMBL30983977 0.81 KCNH2 (0.35) KCNH2TLR7BACE1KDM4EWDR5
SCHEMBL30984028 0.81 MAOA (0.41) KDM4EALDH1A1HPGDHTTPGK1
SCHEMBL30984085 0.75 PSMB1 (0.43) BACE1KDM4EALDH1A1HPGDKDM4C
SCHEMBL30984008 0.73 EGFR (0.39) ALDH1A1SMN1; SMN2
SCHEMBL30984066 0.70 EGFR (0.38) BACE1ALDH1A1WDR5SMN1; SMN2
SCHEMBL30983918 0.70 MAPK1 (0.49) KDM4CMAPK1RAF1HTTSMN1; SMN2
SCHEMBL30983967 0.66 RECQL (0.42) KDM4EALDH1A1HPGDMAPK1HTT
SCHEMBL4307817 0.64 KCNH2 (0.43) KCNH2KDM4EALDH1A1HPGD
SCHEMBL29774129 0.64 L3MBTL1 (0.42) KDM4EALDH1A1HPGDWDR5PDE8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback